Summary
Many drugs have been reported to have caused anaemia. The most serious form involves marrow aplasia, but the way in which this is produced is not understood. A number of drugs lead to megaloblastic anaemia and where this is caused by interference with dihydrofolate reductase the explanation is obvious. However, some substances, notably anticonvulsants, cause megaloblastic anaemia by some other mechanism. A number of drugs cause intestinal bleeding with anaemia as a result. Sideroblastic anaemia is a relatively rare condition, sometimes caused by drugs, particularly those used in the treatment of tuberculosis. Leukaemia very occasionally supervenes in patients with drug-induced aplastic anaemia.
Similar content being viewed by others
References
Bean, R.H.D.: Phenylbutazone and leukaemia. A possible association. British Medical Journal 2: 1552–1555 (1960).
Berchtold, P.; Bolli, P.; Arbenz, U. and Keiser, G.: Intestinale absorptions-störung infolge metforminbehandlung (zur frage der Wirkungsweise der biguanide). Diabetologia 5: 405–412 (1969).
Böttiger, L.E. and Westerholm, B.: Drug-induced blood dyscrasias in Sweden. British Medical Journal 3: 339–343 (1973).
Burns, J.J.; Rose, R.K.; Chenkin, T.; Goldman, A.; Schulert, A. and Brodie, B.B.: The physiological disposition of phenylbutazone (Butazolidin) in man and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 109: 346–357 (1953).
Carpenter, G.: Chloramphenicol eye-drops and marrow aplasia. Lancet 2: 326–327 (1975).
Cobo, A.; Lisker, R.; Cordova, M.S. and Pizzuto, J.: Cytogenic findings in acquired aplastic anaemia. Acta Haematologica 44: 32–36 (1970).
Cunningham, J.L.; Leyland, M.J.; Delamore, I.W. and Price Evans, D.A.: Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia. British Medical Journal 3: 313–317 (1974).
Custer, R.P.: Aplastic anemia in soldiers treated with atabrine (quinacrine). American Journal of Medical Sciences 212: 211–224 (1946).
Dameshek, W. and Colmes, A.: The effect of drugs in the production of agranulocytosis with particular reference to amidopyrine hypersensitivity. Journal of Clinical Investigation 15: 85–97 (1936).
Davis, P.; Ezeoke, A.; Munro, J.; Hobbs, J.R. and Hughes, G.R.V.: Immunological studies on the mechanism of gold hypersensitivity reactions. British Medical Journal 3: 676–678 (1973).
Denman, E.J. and Denman, A.M.: The lymphocyte transformation test and gold hypersensitivity. Annals of the Rheumatic Diseases 27: 582–588 (1968).
Dustin, P.: Action of mitotic poisons on normal and pathological blood cell formation. Sang 21: 297–330 (1950).
Editorial: Prognosis in aplastic anaemia. British Medical Journal 4: 126–127 (1975).
Forni, A. and Moreo, L.: Chromosome studies in a case of benzene-induced erythro-leukaemia. European Journal of Cancer 5: 459–463 (1969).
Girdwood, R.H.: Trimethoprim/sulphamethoxazole: Long-term therapy and folate levels. The Medical Journal of Australia Special Supplement 1: 34–37 (1973a).
Girdwood, R.H.: Drug-induced megaloblastic anaemia, in Girdwood (Ed.) Blood Disorders Due to Drugs and Other Agents, p.49–82 (Excerpta Medica, Amsterdam 1973b).
Halsted, C.H.; Baugh, C.M. and Butterworth, C.E. Jr.: Jejunal perfusion of simple and conjugated folates in man. Gastroenterology 68: 261–269 (1975).
Heinivaara, O. and Palva, I.P.: Malabsorption and deficiency of vitamin B12 caused by treatment with para-aminosalicyclic acid. Acta Medica Scandinavica 177: 337–341 (1965).
Herzig, R.H.; Herzig, G.P.; Bull, M.I.; Decter, J.A.; Lohrmann, H.P.; Stout, F.G.; Yankee, R.A. and Graw, R.G.: Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates. Blood 46: 743–750 (1975).
Hitchings, G.H.: Species differences among dihydrofolate reductases as a basis for chemotherapy. Postgraduate Medical Journal 45 (Suppl.): 7–10 (1969).
Howell, A.; Andrews, T.M. and Watts, R.W.E.: Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced aplastic anaemia. Lancet 1: 65–69 (1975a).
Howell, A.; Andrews, T.M. and Watts, R.W.E.: Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced aplastic anaemia. Lancet 2: 81–82 (1975b).
Jensen, M.K. and Philip, P.: Cytogenic studies in haematological disorders which may terminate in acute leukaemia. Acta Medica Scandinavica 193: 353–357 (1973).
Jensen, M.K. and Roll, K.: Phenylbutazone and leukaemia. Acta Medica Scandinavica 178: 505–513
Kern, P.; Heimpel, H.; Heit, W. and Kubanek, B.: Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced aplastic anaemia. Lancet 1: 1190 (1975).
Lowenthal, R.M.; Goldman, J.M.; Buskard, N.A.; Murphy, B.C.; Grossman, L.; Storring, R.A.; Park, D.S.; Spiers, A.S.D. and Galton, D.A.G.: Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet 1: 353–358 (1975).
Mannheimer, E.; Pakesch, F.; Reimer, E.E. and Vetter, H.: Diehäematologischen Komplikationen der Epilepsiebehandlung mit Hydantoinkörpern. Medizinische Klinik 47: 1397–1401 (1952).
Martelo, O.J.; Manyan, D.R.; Smith, U.S. and Yunis, A.A.: Chloramphenicol and bone marrow mitochondria. Journal of Laboratory and Clinical Medicine 74: 927–940 (1969).
McGuffin, R.; Goff, P. and Hillman, R.S.: The effect of diet and alcohol on the development of folate deficiency in the rat. British Journal of Haematology 31: 185–192 (1975).
Mercier-Parot, L. and Tuchmann-Duplessis, H.: The dysmorphogenic potential of phenytoin: Experimental observations. Drugs 8: 340–353 (1974).
Morley, A.; Trainor, K. and Blake, J.: A primary stem cell lesion in experimental chronic hypoplastic marrow failure. Blood 45: 681–688 (1975).
Nagao, T. and Mauer, A.M.: Concordance for drug-induced aplastic anemia in identical twins. New England Journal of Medicine 281: 7–11 (1969).
Nieweg, H.O.: Aplastic anaemia (panmyelopathy); in Girdwood (Ed.) Blood Disorders Due to Drugs and Other Agents, p.49–106 (Excerpta Medica, Amsterdam 1973).
Nieweg, H.O.; Bouma, H.G.D.; de Vries, K. and Jansz, A.: Haematological side-effects of some anti-rheumatic drugs. Annals of the Rheumatic Diseases 22: 440–443 (1963).
Norris, J.W. and Pratt, R.F.: Folic acid deficiency and epilepsy. Drugs 8: 366–385 (1974).
Parmentier, R.: Etude des lésions cellulaires provoquées par divers phénols et amines aromatiques. Revue Belge de Pathologie et de Medecine Experimentale 22: 1–54 (1952).
Paton, A.: Oral contraceptives and folate deficiency. Lancet 1: 418 (1969).
Pollini, G. and Biscaldi, G.P.: Patogenesi delie alterazioni cariocinetiche indotte dal benzolo sulle cellule emopoietiche embrionarie. Medicina del Lavoro 58: 205–222 (1967).
Rondanelli, E. and Gorini, P.: Effets du benzène sur la mitose érithroblastique. Acta Haematologica 26: 281–302 (1961).
Rowley, J.D.; Blaisdell, R.K. and Jacobson, L.O.: Chromosome studies in pre-leukemia. I. Aneuploidy of group C chromosomes in three patients. Blood 27: 782–799 (1966).
Saita, G.: Benzene induced hypoplastic anaemias; in Girdwood (Ed.) Blood Disorders Due to Drugs and Other Agents, p.127-146 (Excerpta Medica, Amsterdam)
Sanchez-Medal, L.; Castanedo, J.P. and Garcia-Rojas, F.: Insecticides and aplastic anemia. New England Journal of Medicine 269: 1365–1367 (1963).
Shojania, A.M.; Hornandy, G. and Barnes, P.H.: Oral contraceptives and serum folate level. Lancet 1: 1376–1377 (1968).
Shojania, A.M.; Hornandy, G. and Barnes, P.H. Oral contraceptives and folate metabolism. Lancet 1: 886 (1969).
Speidel, B.D. and Meadow, S.R.: Epilepsy, anticonvulsants and congenital malformations. Drugs 8: 354–365 (1974).
Storb, R.; Thomas, E.D.; Buckner, C.D.; Cleft, R.A.; Johnson, F.L.; Fefer, A.; Glucksberg, H.; Giblett, E.R.; Lemer, K.G. and Neiman, P.: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43: 157–180 (1974).
Stowers, J.M. and Smith, O.A.O.: Vitamin B12 and metformin. British Medical Journal 3: 246–247 (1971).
Streiff, R.R.: Folate deficiency and oral contraceptives. Journal of the American Medical Association 214: 105–108 (1970).
Tamura, T. and Stokstad, E.L.R.: The availability of food folate in man. British Journal of Haematology 25: 513–532 (1973).
Tomkin, G.H.; Hadden, D.R.; Weaver, J.A. and Montgomery, D.A.D.: Vitamin B12 status of patients on long-term metformin therapy. British Medical Journal 2: 685–687 (1971).
Toskes, P.P. and Deren, J.J.: Selective inhibition of vitamin B12 absorption by para-aminosalicyclic acid. Gastroenterology 62: 1232–1237 (1972).
Westhoff, D.D.; Samaha, R.J. and Barnes, A.: Arsenic intoxication as a cause of megaloblastic anemia. Blood 45: 241–246 (1975).
Whittaker, J.A. and Price Evans, D.A.: Genetic control of phenylbutazone metabolism in man. British Medical Journal 4: 323–328 (1970).
Wood, J.K.; Goldstone, A.H. and Allan, N.C.: Folic acid and the pill. Scandinavian Journal of Haematology 9: 539–544 (1972).
Yunis, A.A.: Chloramphenicol toxicity; in Girdwood (Ed.) Blood Disorders Due to Drugs and Other Agents, p.107–126 (Excerpta Medica, Amsterdam 1973).
Yunis, A.A. and Bloomberg, G.R.: Chloramphenicol toxicity: Clinical features and pathogenicity. Progress in Hematology 4: 138–159 (1964).
Yunis, A.A.; Smith, U.S. and Restrepo, A.: Reversible bone marrow suppression from chloramphenicol. Archives of Internal Medicine 126: 272–275 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Girdwood, R.H. Drug-Induced Anaemias. Drugs 11, 394–404 (1976). https://doi.org/10.2165/00003495-197611050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197611050-00003